Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
Cancer Prevention02:59

Cancer Prevention

6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
2.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physician Follow-up Among Transgender and Gender Diverse Individuals after Psychiatric Emergency Department Visits and Hospitalizations: A Retrospective Population-Based Cohort Study.

Transgender health·2026
Same author

Quality metrics for perioperative red blood cell transfusion in gastrointestinal cancer surgery: international Delphi consensus.

BJS open·2026
Same author

Provider level facilitators and barriers towards neoadjuvant chemotherapy for triple negative and HER2 + breast cancer: a survey of Ontario surgeons.

Breast cancer research and treatment·2026
Same author

Labels, Language and Other Strategies to Improve Communication About Lowest Grade Ductal Carcinoma in Situ: Qualitative Interviews With Women and Physicians.

Psycho-oncology·2026
Same author

Developing an expert consensus statement on emergency preparedness for cancer care delivery in Canada: a modified Delphi study.

Archives of public health = Archives belges de sante publique·2026
Same author

A novel patient-centered outcome in cancer care, days at home: a scoping review and guide for its future use.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Related Experiment Videos

Improving multidisciplinary cancer conferences: a population-based intervention.

Savtaj S Brar1, Christine Provvidenza, Amber Hunter

  • 1Department of Surgery, University of Toronto, Toronto, ON, Canada.

Annals of Surgical Oncology
|November 8, 2013
PubMed
Summary

A population-based intervention improved access and quality of multidisciplinary cancer conferences (MCCs). The number of MCCs and patients discussed increased, with significant improvements in criterion satisfaction scores across regions.

Related Experiment Videos

Area of Science:

  • Oncology
  • Healthcare Management
  • Quality Improvement

Background:

  • Multidisciplinary cancer conferences (MCCs) are crucial for optimal cancer patient care.
  • Previous studies indicated variable access to MCCs, with only 52% of hospitals offering them in 2007.
  • Cancer Care Ontario established minimum standards and a measurement framework for MCCs in 2006.

Purpose of the Study:

  • To evaluate the impact of a population-based intervention on the quality and accessibility of MCCs.
  • To assess changes in MCC frequency, patient case review, and adherence to standards.

Main Methods:

  • Prospective data collection from October to December 2009, 2010, and 2011.
  • Development of a criterion satisfaction score (CSS) based on MCC frequency, case review type, and staffing.
  • Calculation of MCCs, patients discussed, and CSSs per hospital and region.

Main Results:

  • Data from 13-14 regions were analyzed.
  • The number of MCCs rose from 660 (2009) to 798 (2011).
  • Criterion satisfaction scores significantly improved across all regions between 2009 and 2011 (p < 0.001).

Conclusions:

  • A population-based intervention demonstrated success in enhancing MCC access and quality.
  • The findings support the effectiveness of standardized interventions in improving cancer care coordination.